These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7428335)

  • 21. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
    Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbamazepine in behaviorally disturbed primary dementia patients.
    Ballinger BR
    J Clin Psychiatry; 1990 Dec; 51(12):523-4. PubMed ID: 2258368
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical effects of choline in Alzheimer's disease.
    Etienne P; Gauthier S; Johnson G; Collier B; Mendis T; Dastoor D; Cole M; Muller HF
    Lancet; 1978 Mar; 1(8062):508-9. PubMed ID: 76060
    [No Abstract]   [Full Text] [Related]  

  • 25. [New diagnostic concepts and tools for the dementias--so what?].
    Wallesch CW
    Fortschr Neurol Psychiatr; 2007 Dec; 75(12):691-3. PubMed ID: 18058677
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.
    Fariello RG
    Funct Neurol; 1997; 12(3-4):221-5. PubMed ID: 9218984
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of choline on amnesia in early Alzheimer's disease.
    Signoret JL; Whiteley A; Lhermitte F
    Lancet; 1978 Oct; 2(8094):837. PubMed ID: 81385
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of naloxone in senile dementia: a double-blind trial.
    Reisberg B; Ferris SH; Anand R; Mir P; Geibel V; De Leon MJ; Roberts E
    N Engl J Med; 1983 Mar; 308(12):721-2. PubMed ID: 6338389
    [No Abstract]   [Full Text] [Related]  

  • 30. Randomization model methods for evaluating treatment efficacy in multicenter clinical trials.
    Davis CS; Chung Y
    Biometrics; 1995 Sep; 51(3):1163-74. PubMed ID: 7548700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type.
    Bergamasco B; Scarzella L; La Commare P
    Funct Neurol; 1994; 9(3):161-8. PubMed ID: 7988944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choline in Alzheimers disease.
    Levy R
    Lancet; 1978 Oct; 2(8096):944-5. PubMed ID: 81959
    [No Abstract]   [Full Text] [Related]  

  • 34. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of RBC glycine and choline levels in geriatric patients treated with lithium.
    Pomara N; Banay-Schwartz M; Block R; Stanley M; Gershon S
    Am J Psychiatry; 1983 Jul; 140(7):911-3. PubMed ID: 6407342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of naftidrofuryl in patients with vascular or mixed dementia: results of a multicenter, double-blind trial.
    Emeriau JP; Lehert P; Mosnier M
    Clin Ther; 2000 Jul; 22(7):834-44. PubMed ID: 10945510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 38. Benefits of rivastigmine on attention in dementia associated with Parkinson disease.
    Wesnes KA; McKeith I; Edgar C; Emre M; Lane R
    Neurology; 2005 Nov; 65(10):1654-6. PubMed ID: 16301500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low- and high-dose naloxone in dementia of the Alzheimer type.
    Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM
    Psychopharmacol Bull; 1985; 21(3):680-2. PubMed ID: 3898183
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnosis of dementia and treatment of Alzheimer's disease. Pharmacologic management of disease progression and cognitive impairment.
    van Reekum R; Simard M; Farcnik K
    Can Fam Physician; 1999 Apr; 45():945-52. PubMed ID: 10216793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.